‍

Blake, Wm. The Vision of Christ. 1821.

‍

Swiss researchers have developed a skin patch that triggers cells to release a hormone that helps control blood sugar, offering a potential new diabetes treatment. The patch uses a common heart medication to activate the process.

The patch activates implanted modified cells, triggering the release of GLP-1, a hormone that enhances insulin secretion and reduces appetite.

This approach mimics the body’s natural blood sugar regulation and could also be adapted for other metabolic and autoimmune diseases. While at least a decade from market approval, researchers see this as a major step toward advanced gene-switch-based therapies.